
Hosted by Mayo Clinic · EN

What if repairing damaged cartilage could be done in a single procedure? Using your own cells and the healing signals they need to recover? In this episode of Tomorrow's Cure, host Lindsey Seavert explores RECLAIM, an innovative regenerative medicine approach that combines a patient's own cartilage cells with donor medicinal signaling cells (MSCs) to help repair damaged joints. Joining the conversation are Dr. Daniel Saris and Dr. Mario Hevesi of Mayo Clinic, along with Dr. Christian Lattermann of Mass General Brigham. Together, they discuss why cartilage injuries are so difficult to treat, how RECLAIM works, and why this breakthrough could reshape the future of orthopedic surgery, sports medicine, and joint preservation. The experts also explore the role of stem-cell-inspired therapies, regenerative medicine, hip arthroscopy, knee cartilage repair, and how artificial intelligence may help personalize treatments in the years ahead. How to listen and stay connected: Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode. Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc Connect with Mayo Clinic: Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/ Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/ Follow Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinic Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic

What if the milk you are drinking could help fight cancer? In this episode of Tomorrow's Cure, we explore cholangiocarcinoma and a surprising new approach to targeting it using milk‑derived nanoparticles and precision aptamer‑based delivery. Host Lindsey Seavert is joined by surgical oncologist Dr. Rory Smoot and long‑term survivor and advocate Melinda Bachini to unpack why this cancer is so challenging, what symptoms and treatment paths patients typically face, and how emerging gene‑delivery platforms and AI‑driven discovery are opening new possibilities when standard therapies fall short. Through Melinda’s 16‑year survivorship story and Dr. Smoot’s lab work that literally starts with skim milk from the Mayo Clinic cafeteria, listeners hear how “chemical antibodies” called aptamers can act as molecular keys to deliver therapy directly to cholangiocarcinoma cells, and how computational tools are accelerating the search for new targets. Together, they discuss the emotional and practical realities of living at the edge of what medicine can do today, the expanding landscape of clinical trials, and why innovation in this rare cancer may ripple out to colon, lung and other hard‑to‑treat tumors. How to listen and stay connected: Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode. Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc Connect with Mayo Clinic: Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/ Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/ Follow Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinic Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic

This episode will explore how fluorescenceguided surgery is reshaping precision surgery by allowing surgeons to visualize critical anatomy, such as blood flow, bile ducts, and tumors, that was previously invisible. Dr. Polites and Dr. Lautz are interested in discussing current and emerging applications across perfusion assessment, hepatobiliary surgery, and cancer care, including rare and novel use cases that are improving safety and outcomes, particularly in pediatrics. The conversation should also look ahead to how new fluorescent agents and continued innovation position fluorescenceguided surgery as a platform for the future of surgical care. How to listen and stay connected: Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode. Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc Connect with Mayo Clinic: Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/ Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/ Follow Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinic Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic

What if one of the earliest clues to Alzheimer’s disease could be found during a routine eye exam? In this episode of Tomorrow’s Cure, host Lindsey Seavert sits down with Dr. Oana Dumitrascu, a neurologist at Mayo Clinic, and Dr. Yalin Wang, a researcher at Arizona State University, to explore how retinal imaging and artificial intelligence may help identify signs of Alzheimer’s disease years before symptoms appear. Together, they discuss the science behind “seeing the brain through the eye,” how AI can detect patterns invisible to the human eye, and why earlier detection could transform research, prevention, and patient care. This conversation highlights an exciting intersection of neuroscience, artificial intelligence, and preventive medicine. How to listen and stay connected: Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode. Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc Connect with Mayo Clinic: Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/ Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/ Follow Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinic Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic

This episode explores why carbon ion therapy is becoming one of the most closely watched developments in radiation oncology. The conversation should connect patient need, the engineering scale behind heavy particle therapy, and the larger research questions now shaping how carbon ions may fit alongside photon and proton therapy in the future. How to listen and stay connected: Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode. Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc Connect with Mayo Clinic: Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/ Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/ Follow Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinic Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic

Award-winning journalist Lindsey Seavert is our new host as we explore the innovations changing the landscape of medicine. Featuring conversations with leading physicians, researchers, and medical experts, the new season looks at everything from AI-powered diagnostics and cutting-edge cancer therapies to surgical technologies improving patient care today.Across a new series of in-depth conversations, we explore the breakthroughs that rarely make headlines and the ways medicine continues to evolve. Becoming smarter, more human, and more connected. Whether you are a patient, clinician, or simply curious about where medicine is headed next, Tomorrow’s Cure delivers accessible, thought-provoking insights wherever you listen to podcasts.How to listen and stay connected:Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode. Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc Connect with Mayo Clinic: Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/ Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/ Follow Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinic Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic

Host: Christopher L. Camp, M.D., Creator & Guide | Mayo Clinic Human Optimization Project Guest: Amy Morin, LCSW, Psychotherapist / Mental Strength Coach / International Bestselling Author | Mentally Strong One of the biggest limiters of our mental strength is our very common (usually unintentional) struggle with self-sabotaging behaviors. Since we all feel too busy to do more, maybe the answer is to actually do less? For some behaviors, that is absolutely the case. To help us better understand how we can do less, and be better for it, our expert guest for this episode is bestselling author, Amy Morin. The three big questions she is going to answer for us today are: What exactly is “mental strength?” What are the things we are doing that commonly sabotage our mental strength How can we remove these things from our lives in order to maximize our mental strength? Learn more about the Human Optimization Project at: https://ce.mayo.edu/optimize

Host: Christopher L. Camp, M.D., Creator & Guide | Mayo Clinic Human Optimization Project Guest: Saranya Wyles, M.D., Ph.D., Associate Professor of Dermatology and Regenerative MedicineDirector of Regenerative Dermatology and Skin Longevity LaboratoryMayo Clinic Department of Dermatology, Rochester, MN Your skin is the largest organ in your body, and it does a lot more than just make you look good! It is our primary defense against the outside world and regulates many of our body’s internal functions. Given the major role it plays in our health and overall performance, it is important that we take care of our skin to keep it healthy for as long as possible. Dr. Saryna Wyles is our expert guest here to answer these big questions for us: 1. What does our skin actually do for us and why is skin care so important? 2. How do we make sense of the most common skin care options out there and sort fact from fiction?What are the regular skin care3. practices we should be doing to help us have healthy, vibrant skin life long? Learn more about the Human Optimization Project at: https://ce.mayo.edu/optimize

For people waiting for a lung transplant, every phone call could be life changing. But too many donor lungs are still turned down. In this episode of Tomorrow’s Cure from Mayo Clinic, host Cathy Wurzer explores how ex vivo lung perfusion, or EVLP, is helping turn a “no” into a “maybe” and sometimes a “yes” for patients who are running out of options. Cathy talks with Mayo Clinic cardiothoracic surgeon Dr. Jack Haney and Brandi Zofkie, Associate Vice President at Lung Bioengineering, about how EVLP keeps lungs alive outside the body so experts can better evaluate and sometimes improve them before transplant. They discuss real patient impact, the logistics of making this technology available to more centers and the honest challenges that still remain. Listeners will hear why this innovation matters now and what it could mean for the future of lung transplantation, from expanding the donor pool to offering more second chances to breathe. How to listen and stay connected:• Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode.• Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc Connect with Mayo Clinic:• Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/Follow • Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/Follow • Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinicFollow • Mayo Clinic on Threads: https://www.threads.net/@mayoclinic

Chronic lymphocytic leukemia is the most common leukemia in adults, yet its earliest warning sign often hides in plain sight. Monoclonal B cell lymphocytosis, or MBL, affects millions of adults who may never know they carry this precursor to CLL. In this episode of Tomorrow's Cure from Mayo Clinic, host Cathy Wurzer talks with hematologist Dr. Sameer Parikh and researchers Dr. Susan Slager and Dr. Gerald Marti about how MBL was discovered, what it reveals about inherited risk, and why it matters for infections, second cancers and long term health. The conversation explores how large population studies at Mayo Clinic, advanced genomics, and emerging tools like artificial intelligence and liquid biopsy could change when and how CLL is found, monitored and treated. Listeners will also hear candid discussion about ethics, anxiety and watchful waiting, and how Mayo Clinic's PreCure initiative is rethinking cancer prevention clinics for people living with early warning signs in their blood. How to listen and stay connected:• Subscribe to Tomorrow’s Cure on your favorite podcast app and follow the show so you never miss an episode.• Get the latest health information from Mayo Clinic’s experts—subscribe to Mayo Clinic’s newsletter for free today: https://mayocl.in/3EcNPNc Connect with Mayo Clinic:• Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/Follow • Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/Follow • Mayo Clinic on X (formerly Twitter): https://x.com/MayoClinicFollow • Mayo Clinic on Threads: https://www.threads.net/@mayoclinic